EMUC20

Athens, Greece.

12th European Multidisciplinary congress on Urological Cancers

At the upcoming 12th European Multidisciplinary Congress on Urological Cancers (EMUC20), experts from across and beyond Europe will examine the best practices and challenges in managing genitourinary (GU) malignancies. This leading congress in GU cancers for European medical specialists is set to take place from 12 to 15 November 2020 in Athens, making it the first Greek edition of EMUC.

EMUC20 is a frontline congress that will identify optimal therapies and address gaps in clinical practices in onco-urology. This congress is designed to encourage relevant discussions on innovative treatment, the limits of standard therapies, and the impact of new research outcomes. Its reputation as prime European platform for professional and scientific exchanges in GU oncology has been well-established throughout the years.

The congress brings together esteemed specialists and healthcare professionals from various disciplines, thanks to the collaborative efforts of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU).

Skills training for urologists, radiologists, pathologists and related healthcare professionals are always part of the EMUC Scientific Programme. Dedicated mentors, tutors and key opinion leaders will offer their expertise during the Hands-on Training sessions and specialised courses organised by the European School of Urology (ESU) at EMUC20.

EMUC20 is preceded by the 9th EAU Section of Urological Imaging meeting (ESUI20), the meeting that aims to identify which contemporary imaging methods are beneficial to which situation; and what kind of standardisation of reporting of different urological cancers are to be expected.

Other notable meetings that will be parallel to EMUC20 include meetings of the Young Academic Urologists (YAU) and the EAU Section of Uropathology (ESUP). YAU’s goals and activities centre on the development of the scientific and leadership skills of young urologists. While ESUP examines and promotes clinicopathological topics and the elaboration of minimal standards for uropathological diagnostics.

The congress is accredited by the European Accreditation Council for Continuing Medical Education (an institution of the European Union of Medical Specialists) to provide CME activity for medical specialists.

Come join us and be in the forefront of medical discoveries as EMUC20 casts a critical look at controversial issues and evaluate the insights in clinical practice concerning GU cancers.

We look forward to your participation in Athens in 2020!

EMUC20 will take place at:

Megaron Athens International Conference Centre
Vas. Sofias Ave. & Kokkali St.
115 21 Athens
Greece

For more information on how to get to the venue, please visit this website

For more information on accommodation, please visit this page

An exhibition will be held jointly with the meeting. The exhibition will be open to all technical equipment manufacturers, pharmaceutical companies and scientific publishers. This is a unique opportunity for your company to enhance your corporate visibility among the global urological community, as well as to promote your products and activities to the congress delegates.  The exhibition space will be assigned on a first come, first served basis.

There is also a wide variety of industry options available for the 12th European Multidisciplinary Meeting on Urological Cancers. For information about prices and availability of all industry and exhibition options, please contact:

EMUC Sales Department
T: +31 (0)26 389 1751
F: +31 (0)26 389 1752
sales@uroweb.org

Early deadline: 12 August 2020, 23.59 hrs CET
Late deadline: 29 October 2020, 23.59 hrs CET
You can register here.

You can view the programme here.

Deadline submission: 1 July 2020, 23.59 hrs CET

Check the Congress website here.